Alzheimer's drug gets FDA panel's backing, setting the stage for broader use
Jun 09, 2023, 10:03 PM
A panel of health advisers has given its full support to an Alzheimer’s drug for treatment of early stages of the brain-robbing disease. AP correspondent Norman Hall reports.